Zen Technologies, an Indian defense technology sector company, has granted a significant patent for an innovative “Automated Hard Kill Firearm Mounting System.” The application for patent was filed by the company on October 15, 2022, will be protected by the patent up to October 15, 2042 as per Patent Act 1970, subject to renewal of Patent.
This patent technology aims to redefine military defense capabilities by enhancing the mounting systems for firearms and providing a more precise, automated mechanism for deploying hard kill systems in military applications. The groundbreaking technology marks a significant milestone in Zen Technologies’ pursuit of technological advancements in the defense and security sectors.
Understanding the Automated Hard Kill Firearm Mounting System
This “Automated Hard Kill Firearm Mounting System” developed by Zen Technologies is designed to automatically deploy and control firearms used in defense systems, mainly focusing on vehicles or stationary defense structures. However, this system can play a crucial role in modern military requirements in operations, specifically in countering threats such as incoming projectiles, explosives, or adversarial forces.
By automating the hard kill process, it will reduce the human intervention and maximizes the effectiveness of military hardware during high-stakes operations.
Hard Kill Technology
A “hard kill” defense system means a technology which is designed to physically destroy or neutralize a threat, such as an incoming missile or projectile. The automated firearm mounting system is particularly useful in integrating firearms with hard kill defense mechanisms, which can enhance their accuracy and rapid response during combat.
Key Features of the Automated Hard Kill Firearm Mounting System
1. Automation
This patent technology is designed to rapidly identify and engage threats with minimal human input. This automation is critical and key point for military operations, where speed is essential in dealing with fast-moving or high-priority threats. This technology will ensure that defensive firearms are positioned correctly and are ready to fire at a moment’s notice.
2. Enhanced Accuracy
This technology is engineered to provide enhanced accuracy by using precise sensors and targeting mechanisms. It will ensures that the firearm is mounted and positioned at the optimal angle and trajectory, increasing the likelihood of hitting the intended target during an engagement.
3. Versatility
Zen Technologies’ automated patented technology is easy adaptable and can be used with various types of firearms of defense. Due to it’s flexibility it can be suitable for a wide range of military applications, including armored vehicles, unmanned ground vehicles (UGVs), and stationary defense positions.
4. Real-time Threat Assessment and Response
The system uses advanced algorithms and real-time data analytics to assess threats in real-time by use of sensor and real time feedback system. Once a threat is identified, the system will automatically respond by aligning and firing the mounted firearm at the target.
5. Integration with Other Defense Systems
The automated mounting system is designed to integrate seamlessly with any defense technologies, including radar systems, visual recognition systems, and countermeasure systems due to it’s flexibility of combination.
Potential Applications and Impact
The patented technology hard kill firearm mounting system offers numerous advantages and potential applications in defense sector.
1. Defense Vehicles
2. Unmanned Ground Vehicles (UGVs)
3. Coastal and Border Defense
4. Integration with Drones
5. Civilian and Private Security
Zen Technologies’ Vision for the Future
Zen Technologies, known for its expertise in defense and training sectors, has long focused on developing cutting-edge technologies for modern warfare. This is the 3rd grant in calendar year 2025 and 13th grant in financial year 2024-25 for Zen technology.
Conclusion
This patent for the Automated Hard Kill Firearm Mounting System represents a major leap forward in defense technology for Zen Technologies. This granted technology promises to enhance the precision, speed, and efficiency of military defense systems, which provides greater protection against a wide range of threats. It has potential applications in vehicles, unmanned systems, border defense, and even private security, the patented technology has the ability to shape the future of warfare, advancing the integration of automation into military strategy.
technology
Honda filed a new technology Patent for CG 160 motorcycle
Honda Motorcycle & Scooter India has recently filed a patent for the design of the CG 160, indicating plans to introduce this model to the Indian market. However, Honda CG 160 is already available in Brazil and is popular commuter motorcycle, known for its reliability and efficiency.
Technical Features:
Engine: The news coming out is that CG 160 is powered by a 162.7cc single-cylinder, air-cooled engine. This engine is compatible with both gasoline and ethanol fuels, offering flexibility and improved performance when using ethanol.
Power Output: It delivers approximately 14.4 horsepower at 8,000 rpm and produces 13.8 Nm of torque at 7,000 rpm.
Transmission: The engine is mated to a 5-speed gearbox, providing smooth gear transitions suitable for urban commuting.
Frame and Suspension: The motorcycle features a diamond frame with telescopic front forks and twin shock absorbers at the rear to provide a comfortable ride on various road conditions.
Braking System: It is equipped with disc brakes at both the front and rear wheels, this will enhance stopping power and safety.
Tires: The CG 160 rides on 18-inch alloy wheels, with an 80/100-18 tire at the front and a 90/90-18 tire at the rear end, this configuration provides stability and grip to the vehicle.
Although, the exact launch date in India has not been officially announced, but the recent patent filing suggests that Honda plans to introduce the CG 160 to the Indian market in the near future. The model has been a best-seller in Brazil since 2015, and Honda’s move to patent its design in India indicates a strategic expansion into the Indian commuter motorcycle segment to create place in Indian auto market.
Delhi High Court upheld Controller’s decision under section 10(4)
The Delhi High Court’s decision highlights the importance of fulfilling the detailed disclosure requirements under the Patents Act 1970, particularly in terms of the scope of the claims made in a patent application. The ruling on the patent application by the Regents of the University of California relates to a recombinant Salmonella microorganism-based live vaccine designed to prevent enteric bacterial infections
Key points from the ruling:
Insufficient Disclosure: The court emphasized that the patent application needed for a clear and comprehensive understanding of the invention. This failure resulted in non-compliance with Section 10(4) of the Patents Act, which requires a full description of the invention and the best method of performing it.
Scope of Claims: The Court found that the application broadly claimed the disruption of the gene product in any form, not just through deliberate genetic modifications. This broadness could have led to the inclusion of naturally occurring mutations, which are excluded from patentability under Section 3(c) of the Act. Therefore, the application lacked clarity and precision in defining the scope of what it intended to patent.
Failure to Enable a Skilled Person: The court noted that the patent application did not provide sufficient details for a person skilled in microbiology subject matter to carry out the invention, which is required under Section 10(4)(b) of the Patent Act. The application was seen as incomplete, leaving out important details needed for the invention’s practical implementation.
Incomplete Disclosure: Although the application included examples of deletion mutations in Salmonella, it did not sufficiently cover other forms of mutations, like insertion or substitution. This partial disclosure further contributed to the application’s failure to meet the standards of Section 10(4)(a), which mandates that the invention be fully disclosed.
Impact of the Decision: The Court’s decision focuses the necessity of precise and detailed disclosures in patent applications, particularly when the scope of the invention could potentially cover a wide variety of methods or naturally occurring phenomena. It also highlights the potential issues with vague claims that might lead to patenting something that should not be patentable, such as naturally mutated organisms.
In conclusion, the Delhi High Court upheld the controller’s decision of refusal to grant a patent, reinforcing the importance of clarity and completeness in patent applications for biotechnology-related inventions.
Pharma consultant Agrawal filed patent for new anti-ageing drug
Sanjay Agrawal, a scientific advisor for the US-based Alkomex GBN Pharma Group and an Ahmedabad-based researcher, has filed for a patent for an anti-aging drug formulation aimed at combating aging at the cellular level. The formulation is designed to address the underlying biological processes of aging, potentially offering a groundbreaking approach to age-related issues.
The patent application has been submitted to the Indian Patent Office, marking an important step in the development of this novel treatment. If granted, this patent would secure intellectual property rights for the formulation, allowing Agrawal and the associated pharmaceutical group to potentially commercialize the drug and offer it as a solution to slow or reverse cellular aging.
Agrawal, already holds over 42 patents for unique drug formulations. He claims that other than addressing ageing at a cellular level, this drug has the potential to significantly improve skin health and boost energy levels and enhance overall vitality.
He explained that while chronological ageing is inevitable, biological and psychological ageing differ significantly from one individual to another, influenced by intrinsic and extrinsic factors such as hormonal changes, stress, and lifestyle.
Currently the demand for anti-aging treatments is increasing rapidly in market. This development could spark significant interest in the pharmaceutical industry. However, the drug will undergo extensive testing and regulatory approval to be fully realized in the market, which could take several years.
The patent application has been submitted to the Indian Patent Office, marking an important step in the development of this novel treatment. If granted, this patent would secure intellectual property rights for the formulation, allowing Agrawal and the associated pharmaceutical group to potentially commercialize the drug and offer it as a solution to slow or reverse cellular aging.
Agrawal, already holds over 42 patents for unique drug formulations. He claims that other than addressing ageing at a cellular level, this drug has the potential to significantly improve skin health and boost energy levels and enhance overall vitality.
He explained that while chronological ageing is inevitable, biological and psychological ageing differ significantly from one individual to another, influenced by intrinsic and extrinsic factors such as hormonal changes, stress, and lifestyle.
Currently the demand for anti-aging treatments is increasing rapidly in market. This development could spark significant interest in the pharmaceutical industry. However, the drug will undergo extensive testing and regulatory approval to be fully realized in the market, which could take several years.
Longi sues JinkoSolar for infringement of new patent technology
Longi, has filed lawsuits against JinkoSolar for their patent infringement, both the companies are leading players in the solar industry. The legal actions have been initiated in both countries China and the United States.
In China, Longi has filed the lawsuit at the Jinan Intermediate People’s Court in Shandong and requested an immediate halt to the manufacturing, sales, and offers to sell the allegedly infringing products and other related activities to it. The Court has accepted the case, with an expected trial date of March 20.
In the United States, the lawsuit was filed at the U.S. District Court for the Eastern District of Texas, alleging patent infringement of Jinko Solar’s TOPCon and multiple other unspecified photovoltaic module products.
Longi claims that JinkoSolar has infringed upon its intellectual property (IP) related to solar technology, specifically patents concerning the production and design of solar cells and panels. This dispute comes out as both companies are at the forefront of solar technology innovation. The patents plays a critical role in protecting advancements in the highly competitive solar energy sector.
The lawsuits highlight the ongoing tensions in the renewable energy industry, where patent disputes are becoming increasingly common as companies rush to secure a competitive edge in the rapidly growing market for solar energy products. In these types of cases, the outcome can impact product sales, partnerships, and overall market positioning for the companies involved.
It remains to be seen how these lawsuits will unfold, but they signal the importance of intellectual property rights in the clean energy sector.
In China, Longi has filed the lawsuit at the Jinan Intermediate People’s Court in Shandong and requested an immediate halt to the manufacturing, sales, and offers to sell the allegedly infringing products and other related activities to it. The Court has accepted the case, with an expected trial date of March 20.
In the United States, the lawsuit was filed at the U.S. District Court for the Eastern District of Texas, alleging patent infringement of Jinko Solar’s TOPCon and multiple other unspecified photovoltaic module products.
Longi claims that JinkoSolar has infringed upon its intellectual property (IP) related to solar technology, specifically patents concerning the production and design of solar cells and panels. This dispute comes out as both companies are at the forefront of solar technology innovation. The patents plays a critical role in protecting advancements in the highly competitive solar energy sector.
The lawsuits highlight the ongoing tensions in the renewable energy industry, where patent disputes are becoming increasingly common as companies rush to secure a competitive edge in the rapidly growing market for solar energy products. In these types of cases, the outcome can impact product sales, partnerships, and overall market positioning for the companies involved.
It remains to be seen how these lawsuits will unfold, but they signal the importance of intellectual property rights in the clean energy sector.
Innocan Pharma secure first patent in India for Liposome Injection
Innocan Pharma Corporation has granted its first patent in India for its Liposomal CBD Injection platform. This patent protects the company’s synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of synthetic CBD into the bloodstream.
The LPT-CBD platform has received positive feedback from the U.S. Food and Drug Administration (FDA) following a successful pre-Investigational New Drug (pre-IND) meeting, advancing its development as a non-opioid alternative for chronic pain management.
Developed in collaboration with Professor Chezy Barenholz and Dr. Ahuva Cern from the Hebrew University in Jerusalem, the liposomal drug delivery platform allows for prolonged exposure and maximizes the bioavailability and therapeutic effects of cannabinoids.
This granted patent enhances Innocan’s proprietary value in India’s $55 billion pharmaceutical market, complementing its global patent applications and strengthening its position in the cannabinoid-based therapeutic sector.
Innocan Pharma’s CEO, Iris Bincovich, expressed his views about the patent grant and highlighted the company’s commitment to innovation and the advancement of non-opioid alternatives for chronic pain management.
This development in IP underscores Innocan Pharma’s dedication to expanding its intellectual property portfolio and advancing cannabinoid-based therapies on a global scale.
IT Stock jump after a Patent for new data processing technology
Intense Technologies Ltd. has granted a patent for its invention “Method for Rule-Based Control Processing of Multiple Input Data Ingestions in Parallel,” a development that has positively influenced its stock performance after grant.
Stock Performance Post-Patent Grant:
Share Price Increase: Intense Technologies’ share price rose by approximately 4% after grant of patent, reflecting investor interest in the company’s enhanced technological capabilities.
Current Stock Price: As of February 20, 2025, the stock is trading at ₹94.71, marking a 6.33% increase over the past 24 hours.
Historical Stock Performance:
52-Week Range: The stock has fluctuated between ₹87.66 (low) and ₹178.32(high) over the past year, indicating significant volatility according to market run.
Recent Trends: Over the last three months, the stock has declined by 23.17%, and over the past year, it has decreased by 25.55%.
Investor Considerations:
Although, the recent patent grant has positively impacted the stock price, but it is important to note that Intense Technologies has experienced a 26% decline in share value over the past month.
Before investment in stock of Intense Technologies Ltd, Investors should consider this alongside the company’s financial health, market position, and the potential long-term benefits of the new patent.
In summary, the patent grant may have a favorable short-term effect on Intense Technologies’ share price, but investors should remain mindful of the company’s broader financial performance and market dynamics.
This patent positions Intense Technologies as a leader in large-scale data processing, offering solutions that enhance efficiency and intelligence in data management.
New Technology Patent filed for eco-friendly tire made of eggshells by Stellantis
Stellantis, the automotive giant has filed a patent application in U.S. Patent and Trademark Office for an innovative eco-friendly tire solution that uses eggshells as a key material. This innovative approach to making tires more sustainable by replacing conventional materials like carbon black and silica with calcium oxide (CaO), derived from waste eggshells. This new technology will reduce the environmental impact of its manufacturing processes.
The eggshells are used in combination with other natural ingredients to create a more sustainable tire material. This innovation is particularly important in the context of tires. However, tires are made from various synthetic and petroleum-based materials that contribute to environmental pollution, especially in terms of waste when tires are discarded.
Key Points:
Strength and Durability: The eggshells are made of calcium carbonate, which can provide added strength and stability to the rubber compound, making the tire more durable.
Sustainability: The eggshells is a waste product, which reduce the reliance on synthetic materials and lowers the overall carbon footprint of tire production.
Improved Performance: The invention also suggests that eggshells can enhance traction and fuel efficiency by improving the tire’s performance characteristics.
By incorporating eggshells, the issue of tire waste will solved and by-products or waste from one industry are used in another. This move aligns with the sustainability goals to reduce CO2 emissions and minimize environmental impact across its manufacturing operations.
Although, the eggshell based tire manufacturing is still in its early stages, but if successful, it could have significant implications for the entire automotive and tire industry, potentially leading to greener alternatives for tire production in the future. It also presents a creative way of using biodegradable and abundant waste materials, like eggshells, which are generally discarded.
Honda filed for NWX 125 New Technology Patent in India
Honda has filed a patent application for the NWX 125 scooter in India, which shows indication of potential introduction to the Indian auto market. The NWX 125 is a sporty 125cc scooter currently available in international markets. The features are a sharp front apron, dual LED headlamps, and a single-piece stepped seat. The NWX 125 is powered by a 124cc, single-cylinder engine producing 9.3 BHP and 10 Nm, paired with a continuously variable transmission (CVT). The scooter also includes a digital instrument console and keyless ignition.
Although, the patent filing suggests Honda’s interest in the Indian auto market, but there is no official confirmation of a launch date in India. On introduction, the NWX 125 would compete with models like the TVS Ntorq 125 and Yamaha RayZR 125.
In the meantime, Honda has also filed a patent application for the NT1100 sport-touring motorcycle in India, further indicating the company’s plans to expand its product lineup in the country.
Honda filed for NT1100 new technology patent in India
Honda has filed a patent application in India for the NT1100 Tourer. The bike is already on sale in the European market.
The Honda NT1100 gets sporty style and muscular bodywork. The bike is powered by a 1,084cc parallel-twin engine, delivering nearly 100 horsepower and 116Nm of torque, and offers features such as a TFT display, riding modes, smartphone connectivity, ABS, and traction control. It also includes electronically adjustable Showa front forks and a mono-shock, with braking handled by dual front and a single rear disc mounted on 17-inch wheels.
Although, Honda has not officially announced a launch date for the NT1100 in India, but the design patent filing suggests that the company is about to introduce the model into the Indian auto market. On launch, the NT1100 would compete with other full-sized touring bikes such as the BMW R 1250 RT and the Kawasaki Ninja 1000SX.